Market Overview:
The global plasminogen market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidences of chronic diseases, increasing demand for minimally invasive surgeries, and technological advancements in plasminogen therapy. However, the high cost of treatment and lack of awareness about plasminogen therapy are some factors that may restrain the growth of this market during the forecast period. On the basis of type, intravenous injection is expected to account for a major share of the global plasminogen market during the forecast period. This can be attributed to its advantages over other forms such as eye drops or topical application. Intravenous injection offers faster absorption and higher bioavailability than other forms, which makes it an attractive option for patients requiring urgent treatment.
Product Definition:
Plasminogen is a protein in the blood that is converted into plasmin, which helps to break down clots.
Intravenous Injection:
Intravenous injection is a medical procedure wherein the drugs or fluids are injected into the blood vessels of patient's body by healthcare professionals. Intravenous injections are widely used in various medical procedures such as chemotherapy, hormone replacement therapy, and drug delivery to name a few. The intravenous injection market is expected to grow at an exponential rate over the forecast period owing to increasing prevalence of chronic diseases like cancer & diabetes coupled with rising demand for home care services and supportive government initiatives.
Eye Drops:
An eye drop is a solution used to treat or prevent dry eyes. It is available in various forms such as solutions, tablets, and ointments. Eye drops are available in different concentrations such as single-strength, 2%/4% etc., which can be used for treating mild to severe dry eye conditions.
Application Insights:
Plasminogen is used for the treatment of ligneous conjunctivitis, diabetic foot ulcers, surgical and traumatic wounds, burns injuries and other diseases. The others segment held the largest share in terms of application as well as revenue in 2017. It includes cardiovascular disease (CVD), nephrological disease & urology disorders, periodontology diseases & conditions and infectious diseases. Plasminogen is used for various indications related to these disorders such as acute kidney failure (KF) due to sepsis or trauma associated with CVDs such as heart attack or stroke. Acute kidney failure leads to a reduction in filtration ability leading to an increase in blood pressure which may require dialysis or a kidney transplantation procedure later on.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities, presence of key players, and high healthcare expenditure as a percentage of GDP. In addition, rising number of product launches in this region is also anticipated to contribute toward growth over the forecast period. For instance, FzioMed has launched Plasminogen Concentrate for intravenous use in North America that provides faster results than other existing solutions for ligneous conjunctivitis treatment option (oral drops).
Asia Pacific is expected to grow at a lucrative rate during the same period owing to factors such as improving healthcare infrastructure.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) and cancer
- Rising geriatric population
- Growing demand for minimally invasive surgeries
- Technological advancements in plasminogen therapy
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Plasminogen Market Research Report
By Type
Intravenous Injection, Eye Drops,
By Application
Ligneous Conjunctivitis, Diabetic Foot, Wound Healing, Others,
By Companies
Kedrion, Prometic, Genentech (Roche), Boehringer Ingelheim, Kyowa Hakko Kirin, Omeros Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Plasminogen Market Report Segments:
The global Plasminogen market is segmented on the basis of:
Types
Intravenous Injection, Eye Drops,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ligneous Conjunctivitis, Diabetic Foot, Wound Healing, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kedrion
- Prometic
- Genentech (Roche)
- Boehringer Ingelheim
- Kyowa Hakko Kirin
- Omeros Corporation
Highlights of The Plasminogen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intravenous Injection
- Eye Drops
- By Application:
- Ligneous Conjunctivitis
- Diabetic Foot
- Wound Healing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Plasminogen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Plasminogen is a protein that helps to break down blood clots.
Some of the major companies in the plasminogen market are Kedrion, Prometic, Genentech (Roche), Boehringer Ingelheim, Kyowa Hakko Kirin, Omeros Corporation.
The plasminogen market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Plasminogen Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Plasminogen Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Plasminogen Market - Supply Chain
4.5. Global Plasminogen Market Forecast
4.5.1. Plasminogen Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Plasminogen Market Size (000 Units) and Y-o-Y Growth
4.5.3. Plasminogen Market Absolute $ Opportunity
5. Global Plasminogen Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Plasminogen Market Size and Volume Forecast by Type
5.3.1. Intravenous Injection
5.3.2. Eye Drops
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Plasminogen Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Plasminogen Market Size and Volume Forecast by Application
6.3.1. Ligneous Conjunctivitis
6.3.2. Diabetic Foot
6.3.3. Wound Healing
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Plasminogen Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Plasminogen Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Plasminogen Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Plasminogen Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Plasminogen Demand Share Forecast, 2019-2026
9. North America Plasminogen Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Plasminogen Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Plasminogen Market Size and Volume Forecast by Application
9.4.1. Ligneous Conjunctivitis
9.4.2. Diabetic Foot
9.4.3. Wound Healing
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Plasminogen Market Size and Volume Forecast by Type
9.7.1. Intravenous Injection
9.7.2. Eye Drops
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Plasminogen Demand Share Forecast, 2019-2026
10. Latin America Plasminogen Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Plasminogen Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Plasminogen Market Size and Volume Forecast by Application
10.4.1. Ligneous Conjunctivitis
10.4.2. Diabetic Foot
10.4.3. Wound Healing
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Plasminogen Market Size and Volume Forecast by Type
10.7.1. Intravenous Injection
10.7.2. Eye Drops
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Plasminogen Demand Share Forecast, 2019-2026
11. Europe Plasminogen Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Plasminogen Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Plasminogen Market Size and Volume Forecast by Application
11.4.1. Ligneous Conjunctivitis
11.4.2. Diabetic Foot
11.4.3. Wound Healing
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Plasminogen Market Size and Volume Forecast by Type
11.7.1. Intravenous Injection
11.7.2. Eye Drops
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potentia Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Plasminogen Demand Share, 2019-2026
12. Asia Pacific Plasminogen Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Plasminogen Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Plasminogen Market Size and Volume Forecast by Application
12.4.1. Ligneous Conjunctivitis
12.4.2. Diabetic Foot
12.4.3. Wound Healing
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Plasminogen Market Size and Volume Forecast by Type
12.7.1. Intravenous Injection
12.7.2. Eye Drops
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Plasminogen Demand Share, 2019-2026
13. Middle East & Africa Plasminogen Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Plasminogen Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Plasminogen Market Size and Volume Forecast by Application
13.4.1. Ligneous Conjunctivitis
13.4.2. Diabetic Foot
13.4.3. Wound Healing
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Plasminogen Market Size and Volume Forecast by Type
13.7.1. Intravenous Injection
13.7.2. Eye Drops
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Plasminogen Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Plasminogen Market: Market Share Analysis
14.2. Plasminogen Distributors and Customers
14.3. Plasminogen Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Kedrion
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Prometic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Genentech (Roche)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boehringer Ingelheim
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Kyowa Hakko Kirin
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Omeros Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
